Michels Jean-Jacques, Marnay Jacques, Plancoulaine Benoît, Chasle Jacques
Department of Pathology, Centre François Baclesse, Cannes, France.
Cytometry B Clin Cytom. 2004 May;59(1):32-9. doi: 10.1002/cyto.b.20002.
The aim of the present work was to study the prognostic impact of ploidy and S-phase fraction (SPF) assessed according to recently described methods. These methods of analysis combine different ploidy groups and separate euploid (good) prognostic groups from noneuploid (bad) prognostic groups. The definition of euploidy varied according to the author; some of them even included aneuploid peaks with few events. A comparison was also drawn to the average SPF and the diploid peak SPF observed in aneuploid histograms.
From January 3, 1990 to January 7, 1999, 1,984 previously untreated, invasive breast carcinoma samples were snap-frozen and processed for FCM. The present study evaluated all nondiploid and nonmultiploid histograms, using different analysis patterns and the values of the average SPF and diploid SPF.
SPF is a salient prognostic factor even after multivariate analysis for DFS and MFS. Using several methods of analysis of ploidy and SPF shows that the classical method of analysis involving separation of ploidy according to diploidy versus aneuploidy and analysis of SPF restricted to the aneuploid peak in nondiploid and nonmultiploid histograms is as relevant as other recently proposed patterns of analysis, and that the average SPF or the diploid SPF of aneuploid tumors does not add significant prognostic information.
SPF is a valuable predictor of survival and can be confidently assessed in a simple way by restricting the analysis to the peak of interest (except for multiploid tumors).
本研究的目的是根据最近描述的方法研究倍性和S期分数(SPF)的预后影响。这些分析方法结合了不同的倍性组,并将整倍体(预后良好)组与非整倍体(预后不良)组区分开来。整倍体的定义因作者而异;其中一些甚至包括事件较少的非整倍体峰。还对非整倍体直方图中观察到的平均SPF和二倍体峰SPF进行了比较。
从1990年1月3日至1999年1月7日,对1984例未经治疗的浸润性乳腺癌样本进行速冻并进行流式细胞术检测。本研究使用不同的分析模式以及平均SPF和二倍体SPF值评估了所有非二倍体和非多倍体直方图。
即使在对无病生存期(DFS)和无远处转移生存期(MFS)进行多因素分析后,SPF仍是一个显著的预后因素。使用几种倍性和SPF分析方法表明,经典的分析方法,即将倍性分为二倍体与非整倍体,并将SPF分析仅限于非二倍体和非多倍体直方图中的非整倍体峰,与其他最近提出的分析模式同样相关,并且非整倍体肿瘤的平均SPF或二倍体SPF并未增加显著的预后信息。
SPF是生存的有价值预测指标,通过将分析限制在感兴趣的峰(多倍体肿瘤除外),可以以简单的方式可靠地评估。